| GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib) | |
Heteromer
| 584-1006 | 100 | 2×38O; |
|
| CryoEM structure of the HisRS-like domain of human GCN2 | | homo-2-mer | 1011-1493 | 100 | |
|
| Crystal structure of the RWD domain of human GCN2 - 2 | | homo-2-mer | 17-139 | 100 | |
|
| Crystal structure of the RWD domain of human GCN2 - 1 | | homo-2-mer | 17-138 | 100 | |
|
| Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents | | monomer | 584-1004 | 100 | 1×KA7; |
|
| Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents | | monomer | 584-1003 | 100.0 | 1×KA4; |
|
| Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents | | monomer | 584-1002 | 100 | 1×KAV; |
|
| GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2 | | monomer | 583-998 | 100.0 | 1×G41; |
|